Google accused of selling ads for unproven health supplements

Google has been accused of selling advertisements to companies that offer unapproved dementia and Alzheimer’s treatments, according to The Times, a U.K.-based publication.

Advertisement

The search engine giant reportedly sold ads for retailers showcasing unproven medical treatments under search teams such as “Alzheimer’s pills” and “dementia supplements,” The Times reports. Google has since stopped selling ads under Alzheimer pills and dementia supplements search terms, according to the report.

A spokesperson for Google told the Daily Mail: “We have strict policies that govern the kinds of ads we allow on our platform, and ads for products that offer ‘miracle cures’ for medical ailments are a violation of those policies. When we find ads that violate our policies, we remove them.”

More articles on health IT:
Health Quest, IBM partner on AI tech to boost clinical trial participation
Snapchat pursues ad revenue from pharma companies
6 recent vendor contracts, go-lives

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.